• India
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Opinion
  • States
The Uttam Hindu
  • India
  • World
  • Business
  • Entertainment
  • Lifestyle
  • Sports
  • Opinion
  • States
    • Chandigarh
    • Delhi
    • Haryana
    • Himachal
    • Punjab
Home > #Pharmaceuticals
US May Revise Drug Tariffs, Trump Likely to Announce in Coming Days

US May Revise Drug Tariffs, Trump Likely to Announce in Coming Days

by The Uttam Hindu |2025-10-09 06:05:46
Chhindwara Cough Syrup Case: Pharma Company Owner Arrested from Chennai After Death of 20 Children

Chhindwara Cough Syrup Case: Pharma Company Owner Arrested from Chennai After Death of 20 Children

by The Uttam Hindu |2025-10-09 04:49:20
Punjab Bans ColdRiff Syrup After 10 Child Deaths in Madhya Pradesh

Punjab Bans ColdRiff Syrup After 10 Child Deaths in Madhya Pradesh

by The Uttam Hindu |2025-10-07 06:42:43
‘Killer Cough Syrup’ Scandal: 14 Children Dead, 350 Safety Rules Broken in Factory Exposé

‘Killer Cough Syrup’ Scandal: 14 Children Dead, 350 Safety Rules Broken in Factory Exposé

by The Uttam Hindu |2025-10-07 06:24:35
Prez Trump warns reprieve for pharmaceuticals, major Indian export, to end ‘shortly’

Prez Trump warns reprieve for pharmaceuticals, major Indian export, to end ‘shortly’

by The Uttam Hindu |2025-04-09 09:15:15
Israeli researchers develop AI tool to decode cell responses to drugs

Israeli researchers develop AI tool to decode cell responses to drugs

by The Uttam Hindu |2025-04-02 06:08:45
S. Korea seeks to boost animal medicine market to $2.7 billion by 2035

S. Korea seeks to boost animal medicine market to $2.7 billion by 2035

by The Uttam Hindu |2025-04-02 06:02:32
Celltrion targets $3.46 bn in sales this year on biosimilars

Celltrion targets $3.46 bn in sales this year on biosimilars

by The Uttam Hindu |2025-03-18 10:22:45
Celltrion launches autoimmune disease treatment in US

Celltrion launches autoimmune disease treatment in US

by The Uttam Hindu |2025-03-13 09:32:28
Indian pharma market to grow 8-9 per cent in FY26: Report

Indian pharma market to grow 8-9 per cent in FY26: Report

by The Uttam Hindu |2025-03-10 10:43:51
S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar

S.Korean drugmaker Celltrion gets USFDA approval for allergic asthma biosimilar

by The Uttam Hindu |2025-03-10 08:26:48
Indian Pharma Market Hits Rs 2.24 Trillion in MAT, With 8.1% Yearly Growth

Indian Pharma Market Hits Rs 2.24 Trillion in MAT, With 8.1% Yearly Growth

by The Uttam Hindu |2025-03-08 06:57:59
  • NEXT >
X